Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors - PubMed (original) (raw)
Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
F K Ferrari et al. J Virol. 1996 May.
Abstract
The ability of recombinant adeno-associated virus (AAV) to transduce cells with a marker gene in vitro was found to be substantially increased by the presence of adenovirus. Transfection experiments with adenovirus genomic DNA suggest that this increase is not facilitated by adenovirus-mediated viral uptake but is instead dependent on adenovirus gene expression. Using various adenovirus mutants, we were able to map this function to early-region E4 open reading frame 6. Plasmid expression of open reading frame 6 protein in cells infected with recombinant AAV increased transduction between 100- and 1,000-fold. The increase in transduction was not dependent on the recombinant AAV gene cassette but instead appeared to involve an immediate early step of the AAV life cycle. Chemical and physical agents that have been shown to induce helper-free replication of wild-type AAV were also able to stimulate recombinant AAV transduction, suggesting that the phenomenon might affect AAV DNA replication. Further experiments showed that viral uncoating was not affected and that the rate-limiting step involved synthesis of a second strand on the single-stranded genomic AAV DNA. These data suggest that the adenovirus E4 region, as well as chemical and physical agents, can play an essential role in an immediate-early step of the AAV life cycle, specifically in second-strand synthesis, and have important implications for the use of AAV vectors in gene therapy protocols.
Similar articles
- The adenovirus E4 ORF6 and E1b 55 kDa proteins cooperate in a p53-independent manner to enhance transduction by recombinant adeno-associated virus vectors.
Trahair TN, Alexander IE, Rowe PB, Smythe JA. Trahair TN, et al. J Gen Virol. 2000 Dec;81(Pt 12):2983-2991. doi: 10.1099/0022-1317-81-12-2983. J Gen Virol. 2000. PMID: 11086129 - Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.
Qing K, Wang XS, Kube DM, Ponnazhagan S, Bajpai A, Srivastava A. Qing K, et al. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10879-84. doi: 10.1073/pnas.94.20.10879. Proc Natl Acad Sci U S A. 1997. PMID: 9380728 Free PMC article. - Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
Burova E, Ioffe E. Burova E, et al. Gene Ther. 2005 Oct;12 Suppl 1:S5-17. doi: 10.1038/sj.gt.3302611. Gene Ther. 2005. PMID: 16231055 Review. - Adeno-associated virus infection and its impact in human health: an overview.
Sant'Anna TB, Araujo NM. Sant'Anna TB, et al. Virol J. 2022 Oct 31;19(1):173. doi: 10.1186/s12985-022-01900-4. Virol J. 2022. PMID: 36316711 Free PMC article. Review.
Cited by
- Quantitative 3D tracing of gene-delivery viral vectors in human cells and animal tissues.
Xiao PJ, Li C, Neumann A, Samulski RJ. Xiao PJ, et al. Mol Ther. 2012 Feb;20(2):317-28. doi: 10.1038/mt.2011.250. Epub 2011 Nov 22. Mol Ther. 2012. PMID: 22108857 Free PMC article. - AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy.
Jacobs R, Dogbey MD, Mnyandu N, Neves K, Barth S, Arbuthnot P, Maepa MB. Jacobs R, et al. Microorganisms. 2023 Dec 14;11(12):2985. doi: 10.3390/microorganisms11122985. Microorganisms. 2023. PMID: 38138129 Free PMC article. Review. - Recent advances in gene therapy for atrial fibrillation.
Yoo S, Geist GE, Pfenniger A, Rottmann M, Arora R. Yoo S, et al. J Cardiovasc Electrophysiol. 2021 Oct;32(10):2854-2864. doi: 10.1111/jce.15116. Epub 2021 Jul 6. J Cardiovasc Electrophysiol. 2021. PMID: 34053133 Free PMC article. Review. - Evaluation of the SH-SY5Y cell line as an in vitro model for potency testing of a neuropeptide-expressing AAV vector.
Zanker J, Hüser D, Savy A, Lázaro-Petri S, Hammer EM, Schwarzer C, Heilbronn R. Zanker J, et al. Front Mol Neurosci. 2023 Nov 30;16:1280556. doi: 10.3389/fnmol.2023.1280556. eCollection 2023. Front Mol Neurosci. 2023. PMID: 38098942 Free PMC article. - Stability and Safety of an AAV Vector for Treating RPGR-ORF15 X-Linked Retinitis Pigmentosa.
Deng WT, Dyka FM, Dinculescu A, Li J, Zhu P, Chiodo VA, Boye SL, Conlon TJ, Erger K, Cossette T, Hauswirth WW. Deng WT, et al. Hum Gene Ther. 2015 Sep;26(9):593-602. doi: 10.1089/hum.2015.035. Epub 2015 Jul 29. Hum Gene Ther. 2015. PMID: 26076799 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1969 Nov;64(3):863-9 - PubMed
- J Clin Invest. 1994 Oct;94(4):1440-8 - PubMed
- J Gen Virol. 1970 Dec;9(3):251-5 - PubMed
- J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
- Cell. 1979 Jul;17(3):683-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources